Biotech

All Articles

Eli Lilly hops deeper right into AI along with $409M Genetic Leap bargain

.Eli Lilly has actually sprung into an AI-enabled drug invention offer, partnering along with RNA ex...

After FDA rejection and unemployments, Lykos chief executive officer is leaving behind

.Lykos chief executive officer and owner Amy Emerson is walking out, along with principal functionin...

Novartis sparks new stage of Voyager pact along with $15M capsid offer

.Novartis is opening a brand-new outpost in its own cooperation along with Voyager Rehabs, paying fo...

Lilly articles more beneficial data on its own weekly the hormone insulin possibility

.On the heels of an FDA rejection for its own main competing Novo Nordisk, Eli Lilly is picking up s...

IN 8bio standstills period 2 test, gives up one-half of labor force

.Just a few months after application the first patient in a period 2 test for freshly identified gli...

Lilly, Haya ink $1B biobuck excessive weight deal to look dark genome

.Eli Lilly's hunt for weight problems targets has led it to the dark genome. The Big Pharma has actu...

ArsenalBio raises $325M, turns far from former lead possession

.Arsenal Biosciences is actually moving on up. The tissue therapy company has added on $325 million ...

Lilly- supported weight-loss biotech data IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' cannabis use drug flunks phase 2b, driving Indivior to review $100M possibility

.Aelis Farma's chances of securing a simple, positive decision on a $100 thousand choice remittance ...

ProKidney standstills stage 3 trial certainly not required for tissue therapy approval

.ProKidney has actually quit some of a pair of phase 3 trials for its cell treatment for kidney illn...